| Refixia 3 000 IU powder and solvent for solution for injection EU/1/17/1193/004 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| Refixia 500 IU powder and solvent for solution for injection EU/1/17/1193/001 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| REFLAD 50 mg film-coated tablets PA2179/003/001 |
Itopride hydrochloride |
PRO.MED.CS Praha a.s. |
Marketed |
| Regaine Extra Strength 5% w/v Cutaneous Solution PA23490/038/002 |
Minoxidil |
JNTL Consumer Health (Ireland) Limited |
Marketed |
| Regaine for Men Extra Strength Scalp Foam 5% w/w Cutaneous Foam PA23490/018/001 |
Minoxidil |
JNTL Consumer Health (Ireland) Limited |
Marketed |
| Regaine for Women Extra Strength Scalp Foam 5% w/w Cutaneous Foam PA23490/018/002 |
Minoxidil |
JNTL Consumer Health (Ireland) Limited |
Marketed |
| Regaine for Women Regular Strength 2% w/v Cutaneous Solution PA23490/038/001 |
Minoxidil |
JNTL Consumer Health (Ireland) Limited |
Not marketed |
| Regiocit Solution for haemofiltration PA25288/008/001 |
Sodium citrate, Sodium chloride |
Vantive Belgium SRL |
Marketed |
| Regurin 20 mg coated tablets PA23355/005/001 |
Trospium chloride |
Viatris Healthcare Limited |
Marketed |
| Regurin 20 mg coated tablets PPA0465/281/001 |
Trospium chloride |
PCO Manufacturing Ltd. |
— |
| Regurin 20 mg coated tablets PPA1463/143/001 |
Trospium chloride |
IMED Healthcare Ltd., |
— |
| REKAMBYS 600 mg prolonged-release suspension for injection EU/1/20/1482/001 |
Rilpivirine |
Janssen-Cilag International NV |
— |
| REKAMBYS 900 mg prolonged-release suspension for injection EU/1/20/1482/002 |
Rilpivirine |
Janssen-Cilag International NV |
— |
| REKOVELLE 12 micrograms/0.36 mL solution for injection in a pre-filled pen EU/1/16/1150/004 |
Follitropin delta |
Ferring Pharmaceuticals A/S |
— |
| REKOVELLE 36 micrograms/1.08 mL solution for injection in a pre-filled pen EU/1/16/1150/005 |
Follitropin delta |
Ferring Pharmaceuticals A/S |
— |
| Rekovelle 72 micrograms/2.16 mL solution for injection in a pre-filled pen EU/1/16/1150/006 |
Follitropin delta |
Ferring Pharmaceuticals A/S |
— |
| Relenza 5mg/dose, inhalation powder, pre-dispensed PA1077/011/001 |
Zanamivir |
GlaxoSmithKline (Ireland) Limited |
Not marketed |
| Relestat, 0.5 mg/ml, eye drops, solution PA1824/018/001 |
Epinastine hydrochloride |
AbbVie Limited |
Not marketed |
| Reletrans 10 micrograms/hour Transdermal Patches PA0711/236/002 |
Buprenorphine |
Rowex Limited, |
Marketed |
| Reletrans 15 micrograms/hour Transdermal Patches PA0711/236/003 |
Buprenorphine |
Rowex Limited, |
Marketed |
| Reletrans 20 micrograms/hour Transdermal Patches PA0711/236/004 |
Buprenorphine |
Rowex Limited, |
Marketed |
| Reletrans 5 micrograms/hour Transdermal Patches PA0711/236/001 |
Buprenorphine |
Rowex Limited, |
Marketed |
| Relfydess, 100 units/mL, solution for injection PA1613/005/001 |
Botulinum Toxin Type A |
Ipsen Pharma |
Marketed |
| Relifex 1g film-coated tablets PA23355/039/002 |
Nabumetone |
Viatris Healthcare Limited |
Marketed |
| Relifex 500 mg film-coated Tablets PA23355/039/001 |
Nabumetone |
Viatris Healthcare Limited |
Marketed |
| Relistor EU/1/08/463/004-008 |
Methylnaltrexone bromide |
Bausch Health Ireland Limited |
— |
| Relistor EU/1/08/463/8-11 |
Methylnaltrexone bromide |
Bausch Health Ireland Limited |
— |
| RELISTOR 12 mg/0.6 mL solution for injection EU/1/08/463/1-3 |
Methylnaltrexone bromide |
Bausch Health Ireland Limited |
— |
| Relpax 40 mg film-coated tablets PPA0465/491/001 |
ELETRIPTAN |
PCO Manufacturing Ltd. |
— |
| RELPAX 40 mg film-coated tablets PA23355/049/001 |
ELETRIPTAN |
Viatris Healthcare Limited |
Marketed |
| RELPAX 40 mg film-coated tablets PPA1463/253/001 |
Eletriptan |
IMED Healthcare Ltd., |
— |
| Relvar Ellipta 184 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/13/886/004-006 |
Fluticasone furoate, Vilanterol trifenatate micronised |
GlaxoSmithKline (Ireland) Limited |
— |
| Relvar Ellipta 92 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/13/886/001-003 |
Fluticasone furoate, Vilanterol trifenatate micronised |
GlaxoSmithKline (Ireland) Limited |
— |
| Remegel 800 mg Chewable Tablets PA0979/077/001 |
Calcium carbonate |
Reckitt Benckiser Ireland Ltd |
Not marketed |
| Remicade 100 mg Powder for concentrate for solution for infusion EU/1/99/116/001-5 |
Infliximab |
Janssen-Cilag International NV |
— |
| Remifentanil 1 mg powder for concentrate for solution for injection or infusion PA2059/056/001 |
Remifentanil |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Remifentanil 2 mg powder for concentrate for solution for injection or infusion PA2059/056/002 |
Remifentanil |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Remifentanil 5 mg powder for concentrate for solution for injection or infusion PA2059/056/003 |
Remifentanil |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Remifentanil Noridem 1 mg powder for concentrate for solution for injection or infusion PA1122/014/001 |
Remifentanil |
Noridem Enterprises Limited |
Not marketed |
| Remifentanil Noridem 2 mg powder for concentrate for solution for injection or infusion PA1122/014/002 |
Remifentanil |
Noridem Enterprises Limited |
Marketed |
| Remifentanil Noridem 5 mg powder for concentrate for solution for injection or infusion PA1122/014/003 |
Remifentanil |
Noridem Enterprises Limited |
Marketed |
| REMINYL 4 mg/ml oral solution PPA2306/012/001 |
Galantamine |
Originalis B.V. |
— |
| Reminyl XL 16 mg prolonged-release capsules, hard PPA0465/166/004 |
Galantamine hydrobromide |
PCO Manufacturing Ltd. |
— |
| Reminyl XL 16 mg prolonged-release capsules, hard PPA2306/008/001 |
Galantamine |
Originalis B.V. |
— |
| Reminyl XL 24 mg prolonged-release capsules, hard PPA0465/166/003 |
Galantamine |
PCO Manufacturing Ltd. |
— |
| Reminyl XL 24 mg prolonged-release capsules, hard PPA2306/009/001 |
Galantamine |
Originalis B.V. |
— |
| Reminyl XL 8 mg prolonged-release capsules, hard PPA0465/166/002 |
Galantamine |
PCO Manufacturing Ltd. |
— |
| Remsima 100 mg powder for concentrate for solution for infusion EU/1/13/853/001 |
Infliximab |
Celltrion Healthcare Hungary Kft. |
— |
| Remsima 120 mg solution for injection in pre-filled pen EU/1/13/853/012-014 |
Infliximab |
Celltrion Healthcare Hungary Kft. |
— |
| Remsima 120 mg solution for injection in pre-filled syringe EU/1/13/853/006-011 |
Infliximab |
Celltrion Healthcare Hungary Kft. |
— |